C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 251/66 (2006.01) A61K 31/53 (2006.01) C07D 251/70 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01)
Patent
CA 2318362
The present invention provides pharmaceutical formulations comprising 1,3,5- triazine derivatives. The compounds and formulations of the present invention exhibit a range of activities, including antiviral and antibiotic activities, and the formulations may be used, alone or in combination, as a method of treating a patient in need of antiviral and/or antibiotic therapy. The triazine derivatives of the present invention bind to and inhibit functional nucleic acids, and hence, have broad applicability in the treatment of conditions associated with DNA and RNA viruses.
La présente invention concerne des formulations pharmaceutiques renfermant des dérivés de 1,3,5-triazine. Les composés et formulations de la présente invention déploient toute une gamme d'activités, y compris des activités antivirales et antibiotiques, et les formulations peuvent être utilisées, seules ou combinées, dans le traitement de patients nécessitant une thérapie antivirale et/ou antibiotique. Les dérivés de triazine de la présente invention se lient aux acides nucléiques qu'ils inhibent et, de ce fait, possèdent de nombreuses applications dans le traitement d'états associés aux virus à ADN et à ARN.
Arenas Jaime E.
Cload Sharon T.
Fleming Elizabeth S.
Xiang Yi Bin
Anadys Pharmaceuticals Inc.
Robic
Scriptgen Pharmaceuticals Inc.
LandOfFree
Triazine antiviral compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazine antiviral compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazine antiviral compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1826137